XML 51 R35.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Restricted Stock Granted uring the three months ended March 31, 2020 and 2019, shares were granted as follow:
Grant Period
 
Type
 
Plan
 
Shares Granted
 
Grant Date Fair Value Per Share
 
Vesting Type
 
Vesting Anniversary
 
Percentage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2020
 
Key Employees
 
2015 Equity Incentive Plan
 
51,790

 
$
162.42

(1) 
Time Based
 
20.0% annually over 5 years
2020
 
Executive Officers
 
2015 Equity Incentive Plan
 
46,000

 
$
165.97

(1) 
Time Based
 
20.0% annually over 5 years
2020
 
Executive Officers
 
2015 Equity Incentive Plan
 
69,000

(2) 
$
125.47

(2) 
Market Condition
 
3rd
 
100.0
%
2020
 
Directors
 
2004 Non-Employee Director Option Plan
 
10,200

 
$
147.97

(1) 
Time Based
 
3rd
 
100.0
%
2019
 
Executive Officers
 
2015 Equity Incentive Plan
 
44,000

 
$
115.39

(1) 
Time Based
 
20.0% annually over 5 years
2019
 
Executive Officers
 
2015 Equity Incentive Plan
 
66,000

(3) 
$
115.39

(3) 
Market Condition
 
3rd
 
100.0
%
2019
 
Directors
 
2004 Non-Employee Director Option Plan
 
18,000

 
$
113.68

(1) 
Time Based
 
3rd
 
100.0
%


(1) The fair values of the grants were determined by using the average closing price of our common stock on the dates the shares were issued.
(2) Share-based compensation for restricted stock awards with market conditions is measured based on an estimate of shares expected to vest. We estimate the fair value of share-based compensation for restricted stock with market conditions using a Monte Carlo simulation. At the grant date our common stock price was $165.97. Based on the Monte Carlo simulation we expect 75.6% of the 69,000 shares to vest.
(3) Share-based compensation for restricted stock awards with market conditions is measured based on an estimate of shares expected to vest. We estimate the fair value of share-based compensation for restricted stock with market conditions using a Monte Carlo simulation. At the grant date our common stock price was $115.39. Based on the Monte Carlo simulation we expect 75.1% of the 66,000 shares to vest.